A new report co-commissioned by Politico and the Harvard T.H. Chan School of Public Health, delved deeper into Americans’ outlook regarding the Trump administration’s policies to address prescription drug prices. Though President Donald Trump has called this one of his “greatest priorities,” poll numbers show the country is skeptical.

The Trump administration is taking a wide approach in its efforts to lower drug prices—even considering importing drugs from abroad. 

The Office of Management and Budget (OMB) is reviewing a rule to unlock roughly $10 billion in payments for Affordable Care Act (ACA) insurance providers.

UnitedHealth Group is exploring an acquisition of Tenet Healthcare’s healthcare management subsidiary, Conifer Health Solutions, according to the The Wall Street Journal.

Novartis, one of the world’s biggest pharmaceutical companies, has paused any price hikes on its drugs for the remainder of 2018.

With a stake in two post-acute care companies under its belt, health insurer Humana saw its share price hit a new record high last week.

Retail giant Amazon is in early talk to invest in Medplus, India’s second-largest pharmacy chain, according to FactorDaily.

Proposed changes to the 340B drug pricing program, in addition to other cuts in payments, are being called out by industry associations and providers.

Hospital utilization is slowing down in its growth, according to a recent survey of hospital administrators. The trend underscores the shift across the healthcare system away from high-cost settings toward lower-cost outpatient utilization.

Venture capital funding continues to pour into healthcare startups, and the pace this year is already expected to top 2017's total figure of $15 billion.

U.S. antitrust enforcers might not move to block CVS Health’s acquisition of health insurance company Aetna, Bloomberg reported.

Federal investigators say former HHS Secretary Tom Price wasted $341,000 of taxpayer money for his use of chartered jets and military aircraft, The New York Times reported Friday.